CLINICAL_TRIALS
trial_result
· 2024-06-07
Clinical Trial Update: Biomarker and Genetic Predictors of Erenumab Treatment Response [Phase 4]
Summary
Phase 4 trial evaluating biomarkers and genetic predictors of response to erenumab in migraine; results were posted in 2024.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amgen | Conditions: Migraine | Phase 4 | Status: COMPLETED | Results posted: 2024-06-07